Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

Trial Profile

Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Bupivacaine (Primary) ; Ketorolac
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2017 Status changed from recruiting to completed.
    • 25 Feb 2016 Planned End Date changed from 1 Jun 2015 to 1 Jun 2017, according to ClinicalTrials.gov record.
    • 25 Feb 2016 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2017, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top